Podcasts about medicines

Good morning. How do you feel about mind control? New research from a laboratory in Zurich suggests it may be possible to make people less selfish – by sending electrical currents through their brains. Forty-four volunteers were asked to divide money between themselves and an anonymous partner. Remarkably, when certain neural pathways at the front and back of the head were stimulated, participants gave more away. It sounds like science fiction. But other forms of bio-hacking are, of course, already common: weight-loss drugs, metabolic trackers, sleep technology. Medicines are routinely used to lift mood, sharpen attention, steady anxiety. So why not use science to make us kinder as well? That way, we might all become more beautiful people inside, as well as out. Just imagine it. Wellness centres offering holistic packages, body and soul: Botox top-ups in the morning, altruistic boosting in the afternoon. More seriously, researchers claim this new technology could be used for the treatment of certain brain disorders and prove invaluable for people who struggle with social behaviour. It could be just the nudge they need to become better citizens. It's a wholesome idea. Yet as I read the academic article on this impressive experiment in brain-hacking – forecasting gains in “cooperation, productivity, and cohesion” – I became increasingly uneasy. I was put in mind of Aldous Huxley's dystopian novel Brave New World, published almost a century ago, which describes a civilisation held together not by conscience but by chemistry and conditioning. A terrifying vision. Once virtue is treated as something that can be engineered, the line between encouragement and enforcement grows thin. A society might become more efficient, more compliant, even more outwardly generous, and still lose its soul. Huxley warns that people who allow themselves to be controlled may eventually come to “love their servitude”. Even if such dystopian fears never come to pass, the ambition to control our moral impulses through technology raises questions about the nature of morality. Christian thought has long distinguished between shaping behaviour from the outside and forming the person from within. Charity — what theologians call caritas — is not simply a matter of generous action. Intention matters too: affection that is freely given is what lends acts of generosity their meaning; without it, they risk becoming little more than reflexes. It's fascinating to learn that science can influence our moral behaviour, but it is fatal to confuse this fact with morality itself. The Christian vision insists that a person is more than a set of automatic responses. Morality only makes sense if it is chosen. As a society, we have already surrendered ourselves to our smartphones, our computers, and our digital habits; let's at least fight, while we can, to love one another freely.

In this episode, Dr Aoife Duignan speaks with Dr Mireia Moragas about how to treat headaches in a pregnant person. They discuss what questions physicians should ask themselves when a pregnant person attends the acute ward with headaches, the green and red flags for headaches as well as the medications that are safe during pregnancy. Dr Mireia Moragas is a Consultant Neurologist in Edinburgh where she also runs the Headache Clinic, as well as participating in the acute care of patients with stroke. She has participated in the local and Scottish national headache guidelines as well as the local protocols for management of headache and stroke during pregnancy. Dr Aoife Duignan is a specialist trainee in geriatric and general medicine in South East Scotland. She is also Co-Chair & Vice Chair - Representation for the Trainees and Members' Committee (T&MC). Recording date: 10 November 2025 --Useful Links-- Bumps (Best Use of Medicines in Pregnancy) - https://www.medicinesinpregnancy.org/ Maternity pathway and schedule of care - https://www.gov.scot/publications/maternity-pathway-schedule-care-clinical-guidance-schedule/ National Maternity Network, Management of Headache in Pregnancy Guidance - https://www.perinatalnetwork.nhs.scot/wp-content/uploads/2023/02/2023-02-21-Headache-in-Pregnancy.pdf NHS Scotland Centre for Sustainable Delivery - https://www.nhscfsd.co.uk/media/nswenkmf/national-headache-pathway-migraine-during-pregnancy-and-following-childbirth.pdf RefHelp NHS Lothian - https://apps.nhslothian.scot/refhelp/ RefHelf Migraine/Chronic Headache in pregnancy - https://apps.nhslothian.scot/refhelp/guidelines/neurology/headache/migraine-chronic-headache-in-pregnancy/ -- Follow us -- https://www.instagram.com/rcpedintrainees https://x.com/RCPEdinTrainees -- Upcoming RCPE events -- https://www.rcpe.ac.uk/events -- Become an RCPE Member -- https://www.rcpe.ac.uk/membership/join-college Feedback: cme@rcpe.ac.uk This podcast is from the Trainees & Members' Committee (T&MC) of the Royal College of Physicians of Edinburgh (RCPE).

Program notes:0:38 Removal of fallopian tubes to prevent ovarian ca1:43 129 studies included2:43 Women who no longer desire pregnancy3:40 Technically feasible4:30 New oral PCSK9 inhibitor5:35 Think it's a slam dunk6:08 EHR helping deprescribing in older adults7:08 Two sequential EHR interventions8:08 40% more likely in one group9:08 Something in email less effective9:50 Benefits of knee braces for OA10:50 Brace specific to area of OA12:00 If it results in a placebo effect13:00 End

Magic and Medicines is BACK - just like the ooky-spooky ghosts summoned up by believers in this episode's topic - Spiritualism!As we discuss, philosophically speaking 'Spiritualism' is a big old tradition, involving any belief system rooted in concepts of souls, spirits, or supernatural forces. In the 19th century however, during the Second Great Awakening in upstate New York, Spiritualist ideas from a range of Revivalist traditions combined to make something new.Exploding in popularity following America's Civil War, then booming again in Britain after the Great War, new generations of 'Mediums' had come forth, channeling ghosts and cosmic forces in ways that would have been recognisable in Prophets, Holy Maids and Cunning Folk from the Ancient, Medieval and Renaissance eras.Which is to say, Necromancy was back after a rebrand - and so were its enemies, in the forms of debunkers, prosecutors, and many a Society of Psychical Research.From rapping tables to sudden splurges of ectoplasm, Spiritualist manifestos to Harry Houdini hunting severed hands hidden in delicate places, this one has it all.So, turn off the lights, light some candles, and let's all hold hands...Is there anybody there?!Three Ravens is an English Myth and Folklore podcast hosted by award-winning writers Martin Vaux and Eleanor Conlon.Released on Mondays, each weekly episode focuses on one of England's 39 historic counties, exploring the history, folklore and traditions of the area, from ghosts and mermaids to mythical monsters, half-forgotten heroes, bloody legends, and much, much more. Then, and most importantly, the pair take turns to tell a new version of an ancient story from that county - all before discussing what that tale might mean, where it might have come from, and the truths it reveals about England's hidden past...Bonus Episodes are released on Thursdays plus Local Legends episodes on Saturdays - interviews with acclaimed authors, folklorists, podcasters and historians with unique perspectives on that week's county.With a range of exclusive content on Patreon, too, including audio ghost tours, the Three Ravens Newsletter, and monthly Three Ravens Film Club episodes about folk horror films from across the decades, why not join us around the campfire and listen in?REGISTER FOR THE TALES OF SOUTHERN ENGLAND TOURProud members of the Dark Cast Network.Visit our website Join our Patreon Social media channels and sponsors Hosted on Acast. See acast.com/privacy for more information.

Hey everybody! Episode 184 of the show is out. This episode is a podcast I was interviewed on called Beyond the Courage hosted by Robert Canis. Robert has a really good podcast about holistic healing and I was happy to join him. We spoke about a lot of different aspects of my path and he also really focused on iboga which is not something I speak much about. It was a good interview and Robert did a great job of picking my mind and going into some subjects I don't always speak about. Consider supporting his work if you can. As always, to support this podcast, get early access to shows, bonus material, and Q&As, check out my Patreon page below. Enjoy!To learn more about or contact Jason, visit his website at: https://NicotianaRustica.orgTo learn more about or contact Robert, visit his website at: https://www.beyondthecourage.comTo view the recent documentary, Sacred Tobacco, about my work, visit: https://youtu.be/KB0JEQALI_wI will be guiding our next plant medicine dietas with my colleague Merav Artzi (who I interviewed in episode 28) in:January 2026: our second Remote DietaFebruary 2026: Sacred Valley of PeruJuly 2026: Westport, IrelandNovember 2026: Sacred Valley of PeruIf you would like more information about joining us and the work I do or about future retreats, visit my site at: https://NicotianaRustica.orgIntegration/Consultation call: https://jasongrechanik.setmore.comPatreon: https://patreon.com/UniverseWithinYouTube join & perks: https://bit.ly/YTPerksPayPal donation: https://paypal.me/jasongrechanikWebsite: https://jasongrechanik.comInstagram: https://instagram.com/JasonGrechanikFacebook: https://facebook.com/UniverseWithinPodcastMusic: Nuno Moreno: https://m.soundcloud.com/groove_a_zen_sound & Stefan Kasapovski's Santero Project: https://spoti.fi/3y5Rd4H

Traditional medicines here and in Samoa are being investigated for their potential to treat viral illnesses that afflict people living in the Pacific. A Senior lecturer at Auckland University, Natalie Netzler, has won funding for her indigenous-led work to discover antiviral therapies.

This week we're chatting all about the heritage and folklore of the historic Welsh county of Caernarfonshire, and telling the tale of a very good dog.We begin with two of the county's saints, both connected to a key legend from The Mabinogi, before leaping headlong into the county famous for being the heart of the Kingdom of Gwynedd. We have dramatic coastlines, two of the most stunning castles in all of Wales, more Arthurian legends than you can throw a stick at, and the tallest mountain anywhere south of Scotland.Along the way we discuss stories which echo all over Britain given unique twists in Wales, get haunted by a strangling ghost, spectral nun and the shade of a screaming child all at the same pub, discover the resting place of King Arthur's sword Excalibur, and learn about a demonic beaver/crocodile hybrid who might just be to blame for climate change...Then it's time for this week's story, Martin's telling of "Gelert" - a very famous legend about a boy destined to be a king who's only true friend in the world has four legs and a waggy tail.We hope that you enjoy it, and we will speak to you again on Thursday on a brand new episode of Magic & Medicines!Three Ravens is a Myth and Folklore podcast hosted by award-winning writers Martin Vaux and Eleanor Conlon.Released on Mondays, each weekly episode focuses on a historic county, exploring the heritage, folklore and traditions of the area, from ghosts and mermaids to mythical monsters, half-forgotten heroes, bloody legends, and much, much more. Then, and most importantly, we take turns to tell a new version of an ancient story from that county - all before discussing what that tale might mean, where it might have come from, and the truths it reveals about England's hidden past...Bonus Episodes are released on Thursdays plus Local Legends episodes on Saturdays - interviews with acclaimed authors, folklorists, podcasters and historians with unique perspectives on that week's county.With a range of exclusive content on Patreon too, including audio ghost tours, the Three Ravens Newsletter, and monthly Three Ravens Film Club episodes about folk horror films from across the decades, why not join us around the campfire and listen in?Learn more at www.threeravenspodcast.com, join our Patreon at www.patreon.com/threeravenspodcast, and find links to our social media channels here: https://linktr.ee/threeravenspodcastREGISTER FOR THE TALES OF SOUTHERN ENGLAND TOURProud members of the Dark Cast Network.Visit our website Join our Patreon Social media channels and sponsors Hosted on Acast. See acast.com/privacy for more information.

Hey everybody! Episode 183 of the show is out. In this episode, I spoke with Thoryn Stephens. Thoryn is the CEO and founder of Brain.One which is doing really interesting work in human optimization. We sat down and spoke about his life, how, as a young man, he came across huachuma in Ecuador and how that had a transformative impact on him, various other plant medicines, consciousness, BCI and AI, his work as a molecular biologist, and the future of technology. It was a really interesting conversation, and I think Thoryn has a lot of wisdom and insights to share. As always, to support this podcast, get early access to shows, bonus material, and Q&As, check out my Patreon page below. Enjoy!This episode is sponsored by Real Mushrooms. As listeners, visit their website to enjoy a discount of 25% off your first order: https://www.realmushrooms.com/universeTo learn more about or contact Thoryn, visit his website at: https://brain.oneTo learn more about our work, visit our website: https://NicotianaRustica.org To view the recent documentary, Sacred Tobacco, about my work, visit: https://youtu.be/KB0JEQALI_wI will be guiding our next plant medicine dietas with my colleague Merav Artzi (who I interviewed in episode 28) in:February 2026: Sacred Valley of PeruJuly 2026: Westport, IrelandNovember 2026: Sacred Valley of PeruIf you would like more information about joining us and the work I do or about future retreats, visit my site at: https://NicotianaRustica.orgIntegration/Consultation call: https://jasongrechanik.setmore.comPatreon: https://patreon.com/UniverseWithinYouTube join & perks: https://bit.ly/YTPerksPayPal donation: https://paypal.me/jasongrechanikWebsite: https://jasongrechanik.comInstagram: https://instagram.com/JasonGrechanikFacebook: https://facebook.com/UniverseWithinPodcastMusic: Nuno Moreno: https://m.soundcloud.com/groove_a_zen_sound & Stefan Kasapovski's Santero Project: https://spoti.fi/3y5Rd4H

Oprah Winfrey has been candid this week about her ongoing use of GLP-1 medications like those containing semaglutide, the active ingredient in Ozempic, for weight management. In recent interviews promoting her new book Enough: Your Health, Your Weight, and What It's Like to be Free, co-authored with Yale professor Dr. Ania M. Jastreboff, she shared that she started these weekly injections in 2023 and views them as a lifelong tool, much like blood pressure medicine. Oprah told People magazine she feels no shame in relying on them, explaining that after stopping for six months to test her willpower, she regained 20 pounds despite strict dieting and exercise. She now believes obesity influences overeating through genetics and hormones, freeing her from self-blame after decades of public scrutiny and jokes about her weight.Social media buzzed with debate over her comments on The View, where she said obesity causes overeating rather than the reverse, a view some experts clarify starts with overeating leading to obesity, which then complicates appetite control via elevated hunger hormones. Still, Oprah emphasizes these drugs help by reducing hunger and slowing stomach emptying, as noted by Harvard Health.Meanwhile, regulators issued fresh guidance on GLP-1s this week. The UK's Medicines and Healthcare products Regulatory Agency updated advice for prescribers and patients on semaglutide products like Ozempic and Wegovy, highlighting a small risk of severe acute pancreatitis. They noted about 1.6 million adults in England, Wales, and Scotland used these for weight loss between early 2024 and early 2025, per University College London research. In Canada, generic semaglutide became possible after Novo Nordisk's data exclusivity expired on January 4, promising more affordable options soon.Long-term data reinforces their efficacy. The STEP 5 trial showed once-weekly semaglutide yielding 15.2 percent sustained weight loss at 104 weeks, with mild gastrointestinal side effects like nausea most common. Tirzepatide, a dual agonist, outperformed in the SURMOUNT trials with up to 25 percent loss over 88 weeks. Experts like Dr. Caroline Apovian from Harvard stress indefinite use for best results, alongside diet and exercise, while new oral versions and pipeline drugs like amycretin aim to improve access.Thanks for tuning in, listeners. Come back next week for more. Thanks for listening, please subscribe, and remember—this episode was brought to you by Quiet Please podcast networks. For more content like this, please go to Quiet Please dot Ai.Some great Deals https://amzn.to/49SJ3QsFor more check out http://www.quietplease.aiThis content was created in partnership and with the help of Artificial Intelligence AI

In an era where “there's an app for that” is increasingly the answer, we turn our attention to what digital transformation really means for medicines. Not just convenience and clicks, but safety, understanding, and how people actually experience care.In this episode, hosted by Jamie Hayes, STC, and Gimmo, we're joined by Rahul Singal, Senior Responsible Officer for the Digital Medicines Programme at NHS England. Rahul offers a clear-eyed view of the digitisation of the medicines pathway — from prescribing and dispensing to how patients interact with their medicines through tools like the NHS App.Together, we explore the promise and the pitfalls of digital pharmacy: innovations in community pharmacy, the realities of electronic health records, and the tensions between national ambition and local delivery. This is a conversation about progress — but also about complexity, equity, and what it really takes to make digital healthcare work in practice.Rahul Singal is the Senior Responsible Officer for the Digital Medicines Programme within the Transformation Directorate at NHS England. He leads work to digitise the medicines pathway across the NHS, including e-prescribing, automation, transfer of medicines information, and prescription ordering via the NHS App. He is also Senior Advisor for digital pharmacy and medicines, and Professional Lead for pharmacy in clinical informatics. He has held senior leadership roles across the NHS, including Chief Pharmacist in a London NHS Trust, and was the first Clinical Fellow to the Chief Pharmaceutical Officer, where he led national work on seven-day pharmacy services. Like Gimmo, he holds a Master's in Leadership (Quality Improvement) from Ashridge Executive Education and is a Generation Q Fellow.For our micro-discussion we discuss the paper “Qualitative evaluation of the implementation and national roll-out of the NHS App in England” which examines how the NHS App was implemented during the pandemic and beyond; https://pubmed.ncbi.nlm.nih.gov/39838384/.As with all of our guests, Rahul shares with us his Memory Evoking Medicine, a career anthem and book that has influenced his life. From Prescription to Ocean — A TEDx Talk by Jamie HayesWe're incredibly proud to share that Aural Apothecary co-host Jamie Hayes has taken to the TEDx stage with a thought-provoking talk:  Prescription to Ocean: The Hidden Impact of Medicineshttps://www.youtube.com/watch?v=swCLNaAG5qYJamie explores a fascinating and urgent question: What happens to our medicines once they leave the prescription pad — and how do they impact the world beyond the patient? It's a journey that connects healthcare, the environment, and our shared responsibility for the future. You'll never think about prescribing (or taking) medicines in quite the same way again.Please take a few minutes to watch, reflect, and share — this is a conversation worth having.Please follow us on LinkedIn!Let us know what you think of the show. https://www.linkedin.com/company/auralapothecary/You can listen to the Aural Apothecary playlist here; https://open.spotify.com/playlist/3OsWj4w8sxsvuwR9zMXgn5?si=tiHXrQI7QsGtSQwPyz1KBg You can view the Aural Apothecary Library here;  https://litalist.com/shelf/view-bookcase?publicId=KN6E3OOur website is https://www.theauralapothecary.com/To get in touch follow us on LinkedIn, Bluesky and X @auralapothecary or email us at auralapothecarypod@gmail.com. Don't forget to rate us and comment wherever you have got this podcast from.

We love to hear from our listeners. Send us a message.In episode 121 of Cell & Gene: The Podcast, Host Erin Harris talks to Scribe Therapeutics' CEO and Co-Founder Benjamin Oakes about building next‑generation CRISPR and epigenetic editing tools to move genetic medicine beyond rare disease into common cardiometabolic indications. Oakes shares Scribe's engineered CasX platform and epigenetic silencers, preclinical data from its various programs, and why exquisite specificity and low-dose LNP delivery are essential to treating patients safely. They also explore Scribe's partnerships with Sanofi and Lilly, the company's cardiometabolic-first strategy co-developed with Dr. Jennifer Doudna, and Oakes' conviction that genetic medicines can fundamentally reshape healthspan and the future of preventive cardiovascular care.Subscribe to the podcast!Apple | Spotify | YouTube Visit my website: Cell & Gene Connect with me on LinkedIn

Hardware security is not a new problem, but it is rapidly expanding in both consumer and medical domains due to hyperconnectivity. Medical devices and counterfeit medicines represent a fundamental security challenge. In particular, although counterfeit medicines are not a new issue,the problem continues to worsen as counterfeiting practices become increasingly sophisticated. The counterfeiting of biomedical products poses a serious threat to patient safety, public health, and economic stability in both developed and developing countries, and many current countermeasures remain vulnerable because they provide limited security. In this talk, we will share our work on biomedical hardware security with a focus on pharmaceutical products. We present cyber-physical biomedical security technologies that encode dosage information and authentication into edible biomaterials, enabling serialization, track-and-trace, and authentication at the dosage level. This approach empowers patients to play an active role in combating counterfeit medicines. About the speaker: Young Kim is a professor in the Weldon School of Biomedical Engineering and holds the titles of University Faculty Scholar and Showalter Faculty Scholar at Purdue University. His research centers on co-creating hardware(devices) and software (models) for large-scale societal and healthcare applications. His lab develops hybrid machine learning by combining data analytics with models grounded in optical spectroscopy and light-matter interactions to move beyond big-data, compute-intensive AI and leverage engineers' domain expertise. His work spans optical imaging and spectroscopy, mesoscopic physics, meta materials, cancer research, hardware security, and global health,unified by machine learning and data analytics. His research has been funded by a diverse range of agencies, including NIH, CDC, VA, AFOSR, USAID and Gates Foundation. His primary applications are in global health and rural community health, which address large-scale societal and healthcare challenges in mutually reinforcing ways.

In this thought leadership interview, Steffen Saltofte, Chief Executive Officer at Zentiva and President of Medicines for Europe, reflects on the progress made since the Draghi report set out a roadmap for Europe to strengthen competitiveness, foster innovation, and build resilience. He shares his perspective on where Europe stands today, highlighting persistent challenges in innovation, sustainability, and health security.The discussion explores practical steps to modernise outdated frameworks, reduce regulatory fragmentation, and rebuild manufacturing capacity to ensure reliable access to affordable medicines. Saltofte emphasises the need for predictability, harmonisation, collaboration, and accountability to secure Europe's healthcare future. Watch the full interview for insights into how Europe can maintain its competitive edge in a rapidly evolving global landscape.

Limerick pharmacist and owner of Careplus pharmacy in Adare, Rebecca Barry, joins Joe to talk about the medicine shortage in pharmacies.Image via Getty. Hosted on Acast. See acast.com/privacy for more information.

Ron Renaud, CEO of Waltham, Mass.-based Kailera Therapeutics, on developing GLP-1 based medicines to help people lose weight and live healthier lives.

Send us a textDr. Michael Koren joins Kevin Geddings to explain what "Phase 1" means in the context of clinical research. The doctor talks about how phase 1 is the first time a new investigational treatment is used in a person, but that there is an enormous amount of work that happens before a medication gets to that point. He also discusses the other phases of research, concerns about safety, and why clinical research is so important.Be a part of advancing science by participating in clinical research.Have a question for Dr. Koren? Email him at askDrKoren@MedEvidence.comListen on SpotifyListen on Apple PodcastsWatch on YouTubeShare with a friend. Rate, Review, and Subscribe to the MedEvidence! podcast to be notified when new episodes are released.Follow us on Social Media:FacebookInstagramX (Formerly Twitter)LinkedInWant to learn more? Checkout our entire library of podcasts, videos, articles and presentations at www.MedEvidence.comMusic: Storyblocks - Corporate InspiredThank you for listening!

Send us a textBeyond Medicines: How Pharmacovigilance Professionals Save Lives Without Wearing a White CoatWhat if saving lives didn't require a stethoscope, a hospital ward, or a white coat?In this deeply insightful episode of The Kapeel Gupta Career PodShow, we explore one of the most underrated yet powerful careers in global healthcare — Pharmacovigilance.Behind every medicine you trust is a silent professional analysing safety reports, identifying patterns, and protecting patients across the world. This episode reveals how Pharmacovigilance Professionals quietly safeguard millions of lives without ever meeting a patient face to face.If you are: ✔ A science student who loves healthcare but not hospital routines ✔ Confused between pharmacy, research, and corporate roles ✔ Looking for a stable, global, future-proof career ✔ Interested in drug safety, ethics, and real-world impact— this episode is for you.In this episode, you'll learn:

Program notes:0:38 Childhood vaccinations nationally1:30 Across 45 states and DC2:34 Level of vaccine protection3:34 Professional societies stepping in3:51 Skilled nursing facilities 4:51 Estimated operating capacity5:51 Backups into hospitals6:51 Staffing not returned to pre-pandemic levels7:35 Prescribing patterns of CNS active meds in older adults8:36 Several classes of medication examined9:36 Last line medications9:50 Mifepristone regulation historically10:50 Consistent findings on safety11:50 FDA looking at REMS12:50 End

The Apothecaries are back on the road! In this special live episode, The Aural Apothecary takes the stage at the Bennett Institute for Applied Data Science, hosted at Jesus College, Oxford University, as part of the Institute's 10-year anniversary conference.Our guest is Professor Ben Goldacre — a hero of ours, and the bestselling author of Bad Pharma, whose work has shaped how we think about evidence, transparency, and accountability.Recorded in front of a live audience, we quiz Ben on the actions that followed Bad Pharma: a 13-year appraisal, if you like, of what has changed, what has not, and where good intentions still fall short. Along the way, we explore data in Medicine, storytelling, regulation, and why embedding analysts inside healthcare teams matters if data is to drive learning rather than assurance. A live conversation about evidence, honesty, and the hard work of turning data into better care.As with all of our guests, Ben shares with us his Memory Evoking Medicine, a career anthem and book that has influenced his life. The Bennett Institute,home of OPENPrescribing and OPENSafely : https://www.bennett.ox.ac.uk/Bad Pharma: https://www.theguardian.com/books/2012/oct/17/bad-pharma-ben-goldacre-reviewBetter, Broader, Safer - The Goldacre Report https://www.gov.uk/government/publications/better-broader-safer-using-health-data-for-research-and-analysisFrom Prescription to Ocean — A TEDx Talk by Jamie Hayes We're incredibly proud to share that Aural Apothecary co-host Jamie Hayes has taken to the TEDx stage with a thought-provoking talk:  Prescription to Ocean: The Hidden Impact of Medicines https://www.youtube.com/watch?v=swCLNaAG5qY Jamie explores a fascinating and urgent question: What happens to our medicines once they leave the prescription pad — and how do they impact the world beyond the patient? It's a journey that connects healthcare, the environment, and our shared responsibility for the future. You'll never think about prescribing (or taking) medicines in quite the same way again. Please take a few minutes to watch, reflect, and share — this is a conversation worth having.Please follow us on LinkedIn! Let us know what you think of the show. https://www.linkedin.com/company/auralapothecary/You can listen to the Aural Apothecary playlist here; https://open.spotify.com/playlist/3OsWj4w8sxsvuwR9zMXgn5?si=tiHXrQI7QsGtSQwPyz1KBg  You can view the Aural Apothecary Library here;   https://litalist.com/shelf/view-bookcase?publicId=KN6E3O Our website is https://www.theauralapothecary.com/To get in touch follow us on LinkedIn, Bluesky and X @auralapothecary or email us at auralapothecarypod@gmail.com. Don't forget to rate us and comment wherever you have got this podcast from.

In this episode of the Spiritual Journey Podcast, Nimesh Radia welcomes Kayse Gehret, founder of Microdosing for Healing, for a grounded and heart-led conversation about earth medicines, intention, and spiritual evolution.Together, they explore the transformative yet gentle role of microdosing, why so many are being invited to move from head to heart, and how psilocybin and earth medicines can support healing across the physical, emotional, ancestral, and spiritual bodies. Kayse shares her personal journey, her deepened connection to spirit guides, and how microdosing has supported intuition, creativity, and embodied presence.This conversation also explores ancestral healing, grief release, collective evolution, and why healing can move faster in the current energetic climate when we allow ourselves to feel, trust, and stay connected to the body and the earth.Key Themes

Hey everybody! Episode 180 of the show is out. This episode is a podcast I was interviewed on called Beyond the Pills hosted by Josh Rimany. I was really happy with the interview. It was fairly concise and covered a lot of aspects of my work, predominantly with tobacco and tree medicines. We also spoke about ayahuasca, dieta, and some of Josh's insights as well. I hope you all gain from this episode. Consider checking out and supporting Josh's work as well. As always, to support this podcast, get early access to shows, bonus material, and Q&As, check out my Patreon page below. Enjoy!To learn more about or contact Jason, visit his website at: https://NicotianaRustica.orgTo view Josh's podcast on YouTube, visit: https://www.youtube.com/@BeyondThePillsTo view the recent documentary, Sacred Tobacco, about my work, visit: https://youtu.be/KB0JEQALI_wI will be guiding our next plant medicine dietas with my colleague Merav Artzi (who I interviewed in episode 28) in:February 2026: Sacred Valley of PeruJune 2026: Remote Online Dieta July 2026: Westport, IrelandNovember 2026: Sacred Valley of PeruIf you would like more information about joining us and the work I do or about future retreats, visit my site at: https://NicotianaRustica.org Integration/Consultation call: https://jasongrechanik.setmore.comPatreon: https://patreon.com/UniverseWithinYouTube join & perks: https://bit.ly/YTPerksPayPal donation: https://paypal.me/jasongrechanikWebsite: https://jasongrechanik.comInstagram: https://instagram.com/JasonGrechanikFacebook: https://facebook.com/UniverseWithinPodcastMusic: Nuno Moreno: https://m.soundcloud.com/groove_a_zen_sound & Stefan Kasapovski's Santero Project: https://spoti.fi/3y5Rd4H

Send us a textJoin Heather Binning who hosts this week's special guests Louise Irvine, co-chair of the Clinical Advisory Network on Sex and Gender and Terry Patterson from Thoughtful Therapists.Louise and Terry explain why there are enormous concerns from sector experts regarding the ethical grounds and outcomes competence of the UK puberty blockers trial called ‘Pathway', a medical trial which will involve around 220 children under the age of 16.We hear explanation of the scrutiny stages that UK clinical trials must successfully pass through in order to be granted approval, as well as questioning how this safety net has failed Useful Links ...Clinical Advisory Network on Sex and Gender:  https://can-sg.orgOpen Letter from CAN-SG:  https://can-sg.org/2025/12/18/open-letter-to-wes-streeting-on-the-pathways-puberty-blockers-trial/Thoughtful Therapists:  https://www.thoughtfultherapists.orgNational Institute for Health and Care Research: https://fundingawards.nihr.ac.uk/award/NIHR167530Health Research Authority:  https://www.hra.nhs.uk/planning-and-improving-research/application-summaries/research-summaries/pathways-trial/Medicines & Healthcare products Regulatory Agency:  https://www.gov.uk/government/organisations/medicines-and-healthcare-products-regulatory-agencyCommission on Human Medicines:  https://www.gov.uk/government/organisations/commission-on-human-medicinesIf you enjoyed listening to this podcast and would like to hear more, go to womensrights.network/wrn-podcast to listen, download and subscribe to more of our episodes. And if you'd like to join our conversations, go to womensrights.network/join-wrn

Clare Griffin's book Mixing Medicines: The Global Drug Trade and Early Modern Russia (McGill-Queen's UP, 2022) introduces the reader to the dynamic and complex world of early modern Russian medical drugs, from the enthusiasm for newly imported American botanicals to the disgust at Western European medicines made from human corpses. Based on a unique set of previously unused sources, this book is the first study of how the Russian Empire took part in the early modern global trade in medical drugs. The extensive and detailed records kept by the Moscow court show how ingredients produced elsewhere and passed through the massive, long-distance trade network of the early modern world were finally consumed. Looking at medicine as materia medica gives us a different perspective than when looking at practitioners, texts, and ideas. Erika Monahan is the author of The Merchants of Siberia: Trade in Early Modern Eurasia (Cornell UP, 2016) and a 2023-2024 Alexander von Humboldt Fellow Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/new-books-network

Clare Griffin's book Mixing Medicines: The Global Drug Trade and Early Modern Russia (McGill-Queen's UP, 2022) introduces the reader to the dynamic and complex world of early modern Russian medical drugs, from the enthusiasm for newly imported American botanicals to the disgust at Western European medicines made from human corpses. Based on a unique set of previously unused sources, this book is the first study of how the Russian Empire took part in the early modern global trade in medical drugs. The extensive and detailed records kept by the Moscow court show how ingredients produced elsewhere and passed through the massive, long-distance trade network of the early modern world were finally consumed. Looking at medicine as materia medica gives us a different perspective than when looking at practitioners, texts, and ideas. Erika Monahan is the author of The Merchants of Siberia: Trade in Early Modern Eurasia (Cornell UP, 2016) and a 2023-2024 Alexander von Humboldt Fellow Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/medicine

Clare Griffin's book Mixing Medicines: The Global Drug Trade and Early Modern Russia (McGill-Queen's UP, 2022) introduces the reader to the dynamic and complex world of early modern Russian medical drugs, from the enthusiasm for newly imported American botanicals to the disgust at Western European medicines made from human corpses. Based on a unique set of previously unused sources, this book is the first study of how the Russian Empire took part in the early modern global trade in medical drugs. The extensive and detailed records kept by the Moscow court show how ingredients produced elsewhere and passed through the massive, long-distance trade network of the early modern world were finally consumed. Looking at medicine as materia medica gives us a different perspective than when looking at practitioners, texts, and ideas. Erika Monahan is the author of The Merchants of Siberia: Trade in Early Modern Eurasia (Cornell UP, 2016) and a 2023-2024 Alexander von Humboldt Fellow Learn more about your ad choices. Visit megaphone.fm/adchoices

Clare Griffin's book Mixing Medicines: The Global Drug Trade and Early Modern Russia (McGill-Queen's UP, 2022) introduces the reader to the dynamic and complex world of early modern Russian medical drugs, from the enthusiasm for newly imported American botanicals to the disgust at Western European medicines made from human corpses. Based on a unique set of previously unused sources, this book is the first study of how the Russian Empire took part in the early modern global trade in medical drugs. The extensive and detailed records kept by the Moscow court show how ingredients produced elsewhere and passed through the massive, long-distance trade network of the early modern world were finally consumed. Looking at medicine as materia medica gives us a different perspective than when looking at practitioners, texts, and ideas. Erika Monahan is the author of The Merchants of Siberia: Trade in Early Modern Eurasia (Cornell UP, 2016) and a 2023-2024 Alexander von Humboldt Fellow Learn more about your ad choices. Visit megaphone.fm/adchoices

Clare Griffin's book Mixing Medicines: The Global Drug Trade and Early Modern Russia (McGill-Queen's UP, 2022) introduces the reader to the dynamic and complex world of early modern Russian medical drugs, from the enthusiasm for newly imported American botanicals to the disgust at Western European medicines made from human corpses. Based on a unique set of previously unused sources, this book is the first study of how the Russian Empire took part in the early modern global trade in medical drugs. The extensive and detailed records kept by the Moscow court show how ingredients produced elsewhere and passed through the massive, long-distance trade network of the early modern world were finally consumed. Looking at medicine as materia medica gives us a different perspective than when looking at practitioners, texts, and ideas. Erika Monahan is the author of The Merchants of Siberia: Trade in Early Modern Eurasia (Cornell UP, 2016) and a 2023-2024 Alexander von Humboldt Fellow Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/eastern-european-studies

Ozempic and similar glucagon like peptide 1 medicines remain at the center of the weight loss conversation this week, as new research and renewed celebrity attention highlight both their promise and their limits. According to a January report from the American Society for Metabolic and Bariatric Surgery, scientists reviewing records from more than fifty thousand patients found that people who had bariatric surgery lost about five times more weight over two years than those using weekly glucagon like peptide 1 medicines such as semaglutide, the active ingredient in Ozempic. The analysis, presented at the societys annual scientific meeting and summarized by Science Daily, showed surgery patients averaging roughly fifty eight pounds of weight loss, compared with about twelve pounds for people prescribed Ozempic or related drugs for at least six months. Even among those who stayed on these medicines continuously for a full year, average loss reached only about seven percent of body weight, much lower than the surgical group, underscoring how hard it is for many people to stay on these drugs over time because of cost, side effects, or supply issues. At the same time, obesity specialists quoted this week by Fox News Digital say they expect a major shift in how Ozempic style treatments are used. Rather than being seen only as weight loss shots, doctors are increasingly framing them as whole body metabolic medicines that can lower cardiovascular risk and protect the kidneys and liver, with next generation combinations already in development that may bring greater and more durable weight loss with easier dosing, including daily pills and, in trials, long lasting implants. Against this medical backdrop, Oprah Winfrey continues to shape how many listeners think about Ozempic and weight. In a new People magazine cover story highlighted by AOL in the last few days, she describes her decision to start a glucagon like peptide 1 medicine about two and a half years ago as part of accepting that she lives with the disease of obesity rather than a simple failure of discipline. She explains that understanding obesity as something rooted in genes and biology allowed her to stop blaming herself for decades of weight cycling. Oprah does not name a specific brand in that piece, but she speaks directly to people who see themselves in her story, saying that if obesity runs in your family, it is not your fault and that access to accurate information about medicines, lifestyle changes, and risks should guide decisions, not shame. She also notes that even with medication she still eats carefully and exercises most days, and she expects to remain on a glucagon like peptide 1 treatment long term. For listeners, the message from both the new data and Oprahs comments is that Ozempic and related medicines can be powerful tools, but they are not magic fixes and they work best as part of an ongoing plan that may include surgery, structured exercise, and long term medical follow up. Thanks for listening, please subscribe, and remember this episode was brought to you by Quiet Please podcast networks. For more content like this, please go to Quiet Please dot Ai.Some great Deals https://amzn.to/49SJ3QsFor more check out http://www.quietplease.aiThis content was created in partnership and with the help of Artificial Intelligence AI

In this episode of the Vital Health Podcast, host Duane Schulthess speaks with three experts on accelerated patient access to cancer medicines at ISPOR Europe 2025 in Glasgow, Scotland: Martina Garau: Director at Office of Health Economics Bettina Ryll: Founder at MPNEurope Kathleen Grieve: Director - European Public Policy, Access, Pricing and Affordability Lead at MSD Europe They explore why accelerated access matters when evidence is still emerging, how the APACE framework proposes a structured path from eligibility through reassessment, what it could take to reduce fragmentation across national HTA and reimbursement processes, and why pragmatic pilots and agreed data expectations are central to learning while treating. Key Topics: Accelerated Access: Urgency in life-threatening cancer, uneven uptake across countries, and patient time sensitivity. APACE Framework: Eligibility screening, initial assessment, temporary reimbursement, reassessment, and exit decisions. National Alignment: EU-level assessment versus country decisions, shared principles, local implementation limits. Evidence Uncertainty: Early evidence tradeoffs, real-world data needs, and affordability pressure under uncertainty. Getting Started: Pilot use cases, coalition of the willing, dynamic evidence expectations over time. Opinions expressed are those of the speakers. This podcast was supported by Merck Sharp & Dohme as part of the APACE project, in collaboration with GlaxoSmithKline and AstraZeneca.See omnystudio.com/listener for privacy information.

Australia's medicine regulator, the Therapeutic Goods Administration (TGA), has issued a safety advisory for an Ayurvedic product after detecting high levels of heavy metals, including mercury, lead, arsenic and cadmium. In this podcast, we speak with a qualified Ayurvedic practitioner, Dr Santosh Kumar, who shares insights on how to safely buy Ayurvedic products and what information consumers should look for before purchasing.

In this episode Dr's J and Santhosh explore the medicine behind the music of some well known and lesser known songs. Along the way they cover the rolling stones, mother's little helper Miltown, the first psychiatric drug, the trouble trying to treat the heartbreak of Huey Lewis, the secret history of a spoonful of sugar and sabin sundays, imagine dragons chronic illness song, and a 1930s broadway song about an enthusiastic physician. So sit back and relax as we put a song in your heart of medical knowledge!Further Readinghttps://www.ncbi.nlm.nih.gov/books/NBK548721/https://www.cbc.ca/radio/ondrugs/miltown-a-game-changing-drug-you-ve-probably-never-heard-of-1.4237946Support Us spiritually, emotionally or financially here! or on ACAST+travelmedicinepodcast.comBlueSky/Mastodon/X/Instagram: @doctorjcomedy @toshyfroTikotok: DrjtoksmedicineGmail: travelmedicinepodcast@gmail.comSpotify: https://open.spotify.com/show/28uQe3cYGrTLhP6X0zyEhTPatreon: https://www.patreon.com/travelmedicinepodcast Hosted on Acast. See acast.com/privacy for more information.

Professor Tony Avery,  National Clinical Director for Prescribing for NHS England, discusses safer prescribing of medicines. He highlights the changes he would like to see to enable patients to make genuinely informed decisions, which may also sometimes mean that they decide not to go ahead with a treatment. Tony describes how he believes doctors and patients can work together on initial prescribing decisions,  so that patients can be confident that the benefits of the selected approach outweigh the risks. You can find out more about this podcast on its website and if you would like to support it you can do so via Patreon at or via PayPal. The host of the podcast, Liz Tucker is an award winning medical journalist and former BBC producer and director.  You can follow Liz on X and read further information about the podcast on her Substack newsletter. Medical Evidence Matters with Liz Tucker has been selected by Feedspot as one of the top 15 UK Medical Podcasts https://blog.feedspot.com/uk_medical_podcasts/

Dr. Joe Tafur and Natasha Pentin spoke with Edward James, Ph.D., and Joachim Keppler, Ph.D. Edward brings expertise across pharmacology, psychedelic compounds, and biochemistry. Joachim is a quantum field theory physicist, devoted to the study of consciousness and uncovering its fundamental mechanisms. With their colleagues, they published a paper together in 2022 about DMT, ayahuasca plant medicine, and human consciousness.We had many messages asking for an episode about quantum physics…so here it is! We discuss two different theories of consciousness: the biological processes model that is explained by biological or neurophysiological processes versus the idea that the universe is pervaded by an ubiquitous field of consciousness (which corresponds with the laws of physics). In other words, viewing the brain as a filter, and that it can somehow couple with the larger consciousness. Edward and Joachim explain how related work may eventually lead to further understanding of the therapeutic benefits of psychedelic medicines.Thanks for listening! If you'd like to support the nonprofit Modern Spirit and our podcast, you can make a donation HERE.For more information about Edward and Joachim: • Their article on N,N-dimethyltryptamine and Amazonian ayahuasca plant medicine • DIWISS Research Institute: https://www.diwiss.de/(00:00) Introduction (01:35) Meet Edward James and Joachim Keppler(03:19) Early Experiences with Psychedelics(04:53) Ed's Academic Pursuits and Psychedelic Research(06:39) DMT Hallucinations or Perception & Limits of Explanation (09:08) Quantum Physics and Conscious Processes(11:52) Field Models of Consciousness(18:28) Interaction of Zero-Point Field and the Brain(25:03) Psychedelics & Coupling to the Field (29:46) Plant Spirits, Ayahuasca & Leaving Imprints in the Field (41:13) These “Mystical” Experiences and Mental Health Benefits(44:09) Broadening Definitions of “Mystical” Experiences(48:07) Universal Spirituality and Healing(51:57) Bridging Modern Healthcare and Amazonian Practices(57:22) Conclusion and Examples of Knowledge Exchange

MedboardEurope48% disruption in the EU - I hope you are all healthy: https://health.ec.europa.eu/document/download/13b2c812-b144-4489-af1f-e76af5bc97fd_en?filename=md_availability_study_presentation_2024.pdfConsultation: SCHEER asks you - Are Brain Stimulators for non-medical purpose dangerous: https://health.ec.europa.eu/consultations/scheer-public-consultation-preliminary-scientific-opinion-health-hazards-and-risks-associated-use_enQ&A Medicines used with Medical Devices - Revision 6 with new questions: https://www.ema.europa.eu/en/documents/regulatory-procedural-guideline/questions-answers-implementation-medical-devices-vitro-diagnostic-medical-devices-regulations-eu-2017-745-eu-2017-746_en.pdfEUDAMED is Mandatory - From 28 May 2026: https://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=OJ:L_202502371 - https://health.ec.europa.eu/latest-updates/eudamed-four-first-modules-will-be-mandatory-use-28-may-2026-2025-11-27_enUKBetter Call MHRA - But we don't consult: https://www.gov.uk/guidance/medical-devices-get-regulatory-advice-from-the-mhraStandardISO 10993-1 mutation - Nothing is automatic anymore: https://www.youtube.com/watch?v=AkSZVNSz5a0ISO 18969 draft -  Comments until 28-01-2026: https://www.youtube.com/watch?v=zCR9HlHJ5l0EasyIFUCreate your Labels with EasyIFU - UDI included: https://easyifu.comRest of the WorldArgentinaArgentina: Simplified application - Class I/A or Class II/B: https://www.argentina.gob.ar/noticias/anmat-establece-un-regimen-simplificado-para-la-habilitacion-de-establecimientos  CanadaCanada: Modernization of the MDEL - Some changes: https://www.canada.ca/en/health-canada/services/drugs-health-products/compliance-enforcement/establishment-licences/medical-devices-compliance-bulletin/consultation-modernizing-mdel-framework-phase-ii.htmlCanada: Medical Device License Application - Guidance on how to do it: https://www.canada.ca/en/health-canada/services/drugs-health-products/medical-devices/application-information/guidance-documents/managing-applications-licenses.htmlBrazilBrazil: Digitalisation of Certificates - You can request that online now: https://www.gov.br/anvisa/pt-br/assuntos/noticias-anvisa/2025/anvisa-lanca-nova-ferramenta-para-emitir-certificados-de-dispositivos-medicosPodcastPodcast Nostalgia - Let's review previous podcastsEpisode 363 - The journey of a CRO with Helene Quie: https://podcast.easymedicaldevice.com/363-2/Episode 364 - What is changing with the new ISO 10993-1 with Marina Daineko: https://podcast.easymedicaldevice.com/364-2/Episode 365 - How to become a Lead Auditor with Rob Packard: https://podcast.easymedicaldevice.com/365-2/Social Media to followMonir El Azzouzi Linkedin: https://linkedin.com/in/melazzouziTwitter: https://twitter.com/elazzouzimPinterest: https://www.pinterest.com/easymedicaldeviceInstagram: https://www.instagram.com/easymedicaldevice

This podcast is brought to you by Outcomes Rocket, your exclusive healthcare marketing agency. Learn how to accelerate your growth by going to⁠ outcomesrocket.com A patient's story is the key to better care, yet modern healthcare rarely gives people the time to tell it. In this episode, Chris Brigham, founder of Smart Medical History AI, explains how AI-driven, adaptive patient interviewing can enhance the depth and accuracy of clinical history-taking. He shares his unusual journey from IT pioneer to physician and editor, emphasizing that decades of experience reaffirmed patient history as the cornerstone of good care. Chris describes how his platform conducts a one-hour multilingual interview, verifies the story with the patient, and generates an eight-page clinical summary before the physician enters the room, offering far more insight than passive scribe tools. He also explores global scalability, behavioral health use cases, physician burnout, health literacy, and closes with personal reflections on risk, sailing, music, faith, and a life spanning medicine and technology. Tune in and learn how AI-driven history-taking can transform patient care from the ground up! Resources Connect with and follow Chris Brigham on LinkedIn. Follow Smart Medical History AI on LinkedIn and explore their website!

Everything you want to know about cannabis, but were afraid to ask.   Dr. Riley Kirk is a cannabis research scientist and educator with a Ph.D. in pharmaceutical sciences, specializing in natural product chemistry. Her new book is Reefer Wellness: Understanding Cannabis Science, Culture, and Medicines.   In this episode we talk about: The endocannabinoid system – and how it works in the body The science-backed health benefits of cannabis The risks of cannabis use – including questions about psychosis, schizophrenia, and specific risks for adolescents The fascinating history of the cannabis plant  The criminalization, racism and propaganda machine within that history The legality of cannabis now in the US Different modes of use Where to source your products And much more Join Dan's online community here Follow Dan on social: Instagram, TikTok Subscribe to our YouTube Channel Additional Resources:  Bioactive podcast @cannabichem The Network of Applied Pharmacognosy (NAP) Thanks to our sponsors:  AT&T:   Happy Holidays from AT&T. Connecting changes everything. Airbnb: Your home might be worth more than you think. Find out how much at airbnb.com/host. Function Health:   Visit www.functionhealth.com/Happier or use the gift code Happier25 for a $25 credit towards your membership.      To advertise on the show, contact sales@advertisecast.com or visit https://advertising.libsyn.com/10HappierwithDanHarris  

Blunt Business speaks with Joel Latham, CEO of Incannex Healthcare (NASDAQ: IXHL), a clinical-stage biopharmaceutical company pioneering the use of proprietary combination medicines. Latham breaks down their strategy of fusing synthetic cannabinoids and well-characterized active drug components to target chronic conditions with significant unmet needs, emphasizing a robust intellectual property position and synergistic drug action.Advertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy

Conor Geraghty, Chair of Medicines at Veterinary Ireland, as a suspected case of the Bluetongue virus is discovered in Northern Ireland.

Well we are at the end of another year! 2025 was a big one for us on the podcast! We went to the most herbal events and interviewed so many people! Check out some of our best moments from 2025 and stay tuned for 2026! ⭐January 2025Mutual Aid

Andrew Humberman BioSnap a weekly updated Biography.Andrew Huberman has had a notably active period recently, particularly around major health and wellness events. Most significantly, he appeared as a keynote presenter at the Eudēmonia Summit, which concluded on November sixteenth in West Palm Beach, Florida. This sold-out three-day event attracted a record five thousand attendees and featured more than one hundred fifty world-class experts delivering science-backed health and longevity tools. Huberman shared the stage with other prominent figures including Mark Hyman, Gabby Reece, and Academy Award-winning actress Halle Berry, who serves as an equity owner of Pendulum Therapeutics. The summit represented a major gathering for the wellness industry, with over two hundred seventy expert-led talks across forty venues and more than two hundred fifty on-site treatments ranging from hyperbaric oxygen to advanced recovery modalities.Beyond the summit appearance, Huberman continues to expand his media reach through his Huberman Lab podcast, which remains the number one health and fitness podcast on both Apple Podcasts and Spotify. His recent episode featuring physician-scientist David Fajgenbaum has generated significant engagement, exploring how everyday medicines influence human longevity and aging biology. This conversation centered on repurposing existing drugs to target overlooked biological pathways affecting healthspan, examining how medications like aspirin, tadalafil, lithium, and colchicine interact with inflammatory and metabolic processes central to aging. The episode underscores Huberman's ongoing commitment to translating complex neuroscience into actionable health protocols for general audiences.His digital presence remains substantial, with the Huberman Lab newsletter maintaining over eight hundred thousand subscribers receiving regular emails on neuroscience and health-related tools. The platform has announced a new book project called Protocols, described as an essential guide to improving brain function, enhancing mood and energy, and optimizing physical performance through nervous system rewiring.Regarding his professional standing, Huberman maintains his position as a neuroscientist and tenured professor in the department of neurobiology at Stanford School of Medicine, by courtesy in psychiatry and behavioral sciences. His personal life remains largely private, though he has expressed mindfulness about protecting his family and friends from public attention's impact. Overall, Huberman's recent activities reflect his continued influence in popularizing neuroscience-based health optimization while maintaining academic credibility within the broader wellness industry.Get the best deals https://amzn.to/3ODvOtaThis content was created in partnership and with the help of Artificial Intelligence AI

Our fast-paced lives can make it difficult to perceive the healing properties of the very elements that surround us: in water, fire, air, and earth. Felicia Cocotzin Ruiz, the author of "Earth Medicines", invites us to slow down and receive healing from the earth and its elements. Today, she shares recipes and insights that shed new light on the ancient healing that we may be overlooking which is ubiquitous, if not right under our very noses. Visit Felicia's website: kitchencurandera.com Follow this podcast on the platform of your choice and/or on YouTube Check out our sponsors: Optimal Carnivore and Sirius Nutrition

The Friday Five for November 14, 2025: iPhone Pocket Brings Back… Pockets. CMS Rural Health Transformation Program Government Shutdown Update Most-Favored Nation Drug Pricing CMS GENEROUS Model   Get Connected:

Are cough medicines any better than just taking honey and lemon?When Listener Sally sent in a croaky voicenote to our Sliced Bread Whatsapp number (07543 306807 - put us in your contacts!) we knew we had to tackle this one. Sally didn't think the medicine she used for her cough did very much, so she joined presenter Greg Foot and Jacky Smith, Professor in Respiratory Medicine at the University of Manchester, to get some answers.Each episode Greg investigates the latest ad-hyped products and trending fads promising to make us healthier, happier and greener. Are they really 'the best thing since sliced bread' and should you spend your money on them?If you've seen an ad, trend or wonder product promising to make you happier, healthier or greener, email us at sliced.bread@bbc.co.uk or send a voice note to our WhatsApp number, 07543 306807.RESEARCHER: PHIL SANSOM PRODUCERS: SIMON HOBAN AND GREG FOOT

Are cough medicines any better than just taking honey and lemon?When Listener Sally sent in a croaky voicenote to our Sliced Bread Whatsapp number (07543 306807 - put us in your contacts!) we knew we had to tackle this one. Sally didn't think the medicine she used for her cough did very much, so she joined presenter Greg Foot and Jacky Smith, Professor in Respiratory Medicine at the University of Manchester, to get some answers.Each episode Greg investigates the latest ad-hyped products and trending fads promising to make us healthier, happier and greener. Are they really 'the best thing since sliced bread' and should you spend your money on them?If you've seen an ad, trend or wonder product promising to make you happier, healthier or greener, email us at sliced.bread@bbc.co.uk or send a voice note to our WhatsApp number, 07543 306807.RESEARCHER: PHIL SANSOM PRODUCERS: SIMON HOBAN AND GREG FOOT

Many people in our community say it has become virtually impossible to shift the weight since cancer and menopause. So of course we ask ourselves: What role do GLP-1 medicines play in cancer survivorship and what do we really know about their safety, risks, and benefits? In this episode, I'm joined by Caroline Tweedie, currently working as the lead cancer nurse in the North East of England. With over 17 years' experience as a Clinical Nurse Breast Specialist, Caroline has dedicated her career to improving the lives of those affected by breast cancer and sits on the NICE committee shaping national breast cancer guidance.We explore, with curiosity - and never with judgement:- What GLP-1 medicines are and why they are so effective- Safety concerns and what the evidence shows for cancer survivors- Why these drugs matter in breast cancer survivorship- The role of GLP-1s in weight, muscle, bone health, inflammation, and fatigue- Natural strategies that may work on similar pathways- Key risks to be aware of: hair loss, sarcopenia, drug absorption, and endocrine therapy interactions- What happens when you stop taking the drug- Practical advice for patients and clinicians navigating this new landscapeCaroline also shares her insights on why weight loss isn't the same as fitness, why muscle is the “anti-fatigue organ,” and what both patients and healthcare professionals need to know before considering GLP-1 use in survivorship care.This is a nuanced, evidence-based discussion that puts patients at the centre. Whether you're a survivor curious about GLP-1s or a healthcare professional supporting patients, this episode offers clarity, compassion, and practical takeaways.Episode Highlights:00:00 Intro12:09 Survivorship Challenges Beyond Cancer Treatment15:35 Weight Loss Treatments: Risks & Support16:42 Bariatric Surgery vs Rapid Weight Loss22:18 Protein Intake for Menopause Health25:04 "Deciding on GLP1 Treatment"29:06 GLP-1 Eligibility Criteria Explained35:40 "Drug Trials and Patient Safety"42:19 Obesity Support After Cancer43:31 Diabetes Drugs, Costs, Future HopeConnect with us:For more information and resources visit our website: www.menopauseandcancer.org Or follow us on Instagram @menopause_and_cancerJoin our Facebook group: www.facebook.com/groups/menopauseandcancerchathub

The UK's medicines watchdog has said criminal gangs in the UK have started making their own weight-loss drugs, with packaging and branding designed to look like legitimate products. The Medicines and Healthcare products Regulatory Agency (MHRA) has warned that the new trend poses a significant threat. Presenter Clare McDonnell is joined by Sukhi Basra, vice chair of the National Pharmacy Association who also runs a weight loss practice, to dicuss the risks. 'Buy now, pay later' credit schemes are increasingly being used to pay for everyday items like food, bus passes and school uniforms. Leading debt advisors have told the BBC that more women are juggling these debts as they struggle to cope with the cost of living. BBC Yorkshire investigations reporter, Stephanie Miskin, and Rebecca Routledge from debt advice organisation Money Wellness talk to Clare. Jackie Clune is an actor, writer and performer whose eclectic career has included a Karen Carpenter tribute act, Shakespeare, Mamma Mia! and most recently the narrator in a UK tour of The Rocky Horror Show. On screen, she's familiar to many as Motherland's school secretary Mrs Lamb, but she's also written novels and a memoir about unexpectedly becoming a mum to triplets at 39 and finding herself with four children under 19 months. She's now on stage in The Meat Kings! (Inc.) of Brooklyn Heights at London's Park Theatre, playing a tough, no-nonsense boss fighting to keep the family business afloat. She joins Clare to discuss the play, parenting and grief. A rare 500-year-old English parchment birth scroll is to be shown in the UK for the first time following recent pioneering analysis that confirmed its use during pregnancy and childbirth. The medieval scroll is central to Expecting: Birth, Belief and Protection at the Wellcome Collection exploring the protective practices and beliefs around pregnancy, childbirth and infertility that existed in medieval times. Dr Elma Brenner, Research Development Lead at Wellcome Collection and Professor Valerie Worth, Fellow of Trinity college oxford who holds a research grant from the Leverhulme Trust talk to Clare.Presented by: Clare McDonnell Produced by: Dianne McGregor

Dr. Leah Pierson says that, to settle any open questions about both Tylenol and other medications, drugmakers must do something uncomfortable.

For this month's Magic and Medicines Bonus Episode, we're talking all about Reiki!We have a bit more direct experience with this one than some of our past topics, as we completed our First Degree Reiki qualification this summer over the Solstice.Our conversation digs into the theory and history behind Reiki, its development by Mikao Usui and subsequent spread to the West, along with the establishment of the Usui Shiki Ryoho lineage. We look at the Five Principles which provide an ethical underpinning for the practice of Reiki, and talk about the practicalities of Reiki healing, along with the many different permutations of the system.And, of course, tell the story of how it made its way down to us!Three Ravens is an English Myth and Folklore podcast hosted by award-winning writers Martin Vaux and Eleanor Conlon.Released on Mondays, each weekly episode focuses on one of England's 39 historic counties, exploring the history, folklore and traditions of the area, from ghosts and mermaids to mythical monsters, half-forgotten heroes, bloody legends, and much, much more. Then, and most importantly, the pair take turns to tell a new version of an ancient story from that county - all before discussing what that tale might mean, where it might have come from, and the truths it reveals about England's hidden past...Bonus Episodes are released on Thursdays plus Local Legends episodes on Saturdays - interviews with acclaimed authors, folklorists, podcasters and historians with unique perspectives on that week's county.With a range of exclusive content on Patreon, too, including audio ghost tours, the Three Ravens Newsletter, and monthly Three Ravens Film Club episodes about folk horror films from across the decades, why not join us around the campfire and listen in?Learn more at www.threeravenspodcast.com, join our Patreon at www.patreon.com/threeravenspodcast, and find links to our social media channels here: https://linktr.ee/threeravenspodcast Proud members of the Dark Cast Network.Visit our website Join our Patreon Social media channels and sponsors Hosted on Acast. See acast.com/privacy for more information.

Billions of people do not have access to medicines that could save their lives. The Med Aditis Foundation is a non-profit organization that builds partnerships to improve access to high-quality medicines. On this episode, we talk with Bob Blouin, President and CEO of the Med Aditis Foundation.

Donate (no account necessary) | Subscribe (account required) Join Bryan Dean Wright, former CIA Operations Officer, as he dives into today's top stories shaping America and the world. In this episode of The Wright Report, we cover a deadly shooting at an ICE facility in Texas, Gavin Newsom's taunts against federal immigration agents, a trillion-dollar bet on artificial intelligence, and surprising medical news about how common drugs damage the gut. From political violence in Dallas to AI schemes and gut health science, today's brief delivers facts and analysis shaping America's future.   ICE Facility Shooting in Dallas: Joshua Jahn, 29, opened fire on an ICE building with a Mauser-style rifle, killing one illegal alien and injuring two others before taking his own life. He left behind ammo marked “Anti-ICE” and had ties to Communist views similar to his leftist sister. Bryan warns the pattern echoes other recent attacks: “From Trump's assassin in Butler, PA… to Charlie Kirk's killer… these platforms like Steam and Discord are being used to groom young men into violence.”   Newsom Taunts ICE After Signing Five Bills: California Governor Gavin Newsom declared, “To ICE, unmask yourselves. What are you afraid of?” on Colbert's show, less than 24 hours before the Dallas attack. Leftist groups in California are doxxing ICE officers with help from AI activists in Europe, while Democrats push to weaken federal deportation powers. Bryan argues this is about political power, not civil rights: “Schumer and Pelosi said it themselves — they want illegals turned into citizens for votes and control.”   The AI Revolution's Cost and Scheming Risks: OpenAI, Oracle, and SoftBank pledged $500 billion for new U.S. data centers, with utilities warning of grid strain and soaring bills. While AI is helping detect Parkinson's and cancers, researchers admit models are “scheming” — purposely failing to hide competence. Bryan quips, “We're spending a trillion dollars to create systems that lie, hallucinate, and dumb down doctors.”   Common Medications Alter Gut Health for Years: Estonian researchers found antidepressants, beta-blockers, proton pump inhibitors, and benzodiazepines disrupt the gut microbiome as severely as antibiotics. Effects persist long after use, raising risks for diseases like cancer and Alzheimer's. Bryan advises, “If you're on meds, don't forget about your belly — diet, sleep, and exercise matter.”   "And you shall know the truth, and the truth shall make you free." - John 8:32     Keywords: Dallas ICE facility shooting Joshua Jahn, Anti-ICE ammo Mauser rifle, Discord Steam radicalization grooming, Gavin Newsom Colbert ICE taunt, California ICE officer doxxing AI, Schumer Pelosi immigration citizenship votes, OpenAI Oracle SoftBank Stargate $500B, AI data center electricity water grid strain, AI scheming OpenAI ChatGPT, Estonia gut microbiome drugs study, antidepressants beta-blockers proton pump inhibitors benzos, long-term gut health risks cancer Alzheimer's